EPCAM and colorectal carcinoma: Our results reinforce those from Ostenfeld et al., that reported a significant higher expression of miR-222 in EpCAM+ EVs from CRC compared to healthy donors34, and from Fangfang et al. that correlated exosomal miR-92a expression to clinical stage of CRC patients35.